Immunochemotherapy with obinutuzumab or rituximab in previously untreated follicular lymphoma in the randomized phase III Gallium study: analysis by chemotherapy regimen.
Authors
Hiddemann, WBarbui, A
Albendea, M
Cannell, P
Collins, G
Durig, J
Forstpointner, R
Herold, Manfred
Hertzberg, M
Klanova, M
Radford, John A
Tobinai, K
Burciu, A
Fingerle-Rowson, G
Nielsen, T
Wolbers, M
Marcus, R
Affiliation
Ludwig Maximilians Univ Munchen, Dept Med 3, MunichIssue Date
2017